纳米材料在生物医学检测中的应用

纳米技术的兴起,对生物医学领域的变革产生了深远的影响。纳米材料是纳米技术发展的重要基础,它具有许多传统材料所不具备的独特的理化性质,因此在生物医学、传感器等重要技术领域有着广泛的应用前景。对几类常见的纳米材料包括纳米金、量子点、磁性纳米粒子、碳纳米管和硅纳米线在蛋白质、DNA、金属离子以及生物相关分子检测方面的应用进行综述。     

普鲁士蓝纳米粒子在生物医学诊断和治疗中的应用及进展

随着生物医学诊断和治疗的持续深入研究,出现了多种医学诊断和治疗新方法,为人类的健康提供了更大的保证,其中纳米生物技术在生物医学诊断和治疗中的应用日益增多,基于纳米技术,开发传统材料的生物医学新应用成为了人们的研究热点。普鲁士蓝是一种历史悠久的蓝色染料,其制备过程简单、绿色、成本低,化学结构稳定,具有优良的物理、化学、光学以及磁性等性能,已经在许多领域得到了广泛的应用。近年来,普鲁士蓝开始在生物医学诊断和治疗领域中崭露头角,它已经成功的被开发为新型的核磁共振造影剂和光声成像造影剂,并且在药物输送系统和光热治疗等领域也开始占有一席之地,开发基于纳米技术的普鲁士蓝的生物医学应用已经成为极具吸引力的研究方向。本文对普鲁士蓝在生物医学诊断和治疗中的应用及进展进行综述。     

纳米生物技术的医学应用及研究进展

纳米技术是指对1~100纳米范围内对物质和材料进行研究处理的技术。纳米生物技术是纳米技术中的一个重要研究领域,近些年在医学中有着非常广泛的应用前景。我国与发达国家相比在纳米生物技术方面起步较晚,但是近几年在生物医药领域的研究也先后取得了一定的研究进展。本文就我国纳米生物技术在医学上的应用进行了综述,希望对推进纳米生物技术的进一步发展起到推动作用。     

健康、安全与环境纳米技术标准化研究进展

随着纳米科技的迅速发展和应用,纳米技术对人类和环境的影响引起了广泛的关注.针对纳米从业人员的职业健康、环境保护和消费者安全,需要在不断深入研究纳米毒理学的基础上,开展纳米材料生物效应检测与评价、职业暴露剂量数据采集及控制等方面的标准化工作.本文简要回顾了纳米生物技术相关标准化工作的发展历史和演变,介绍了中国及国际标准化组织在纳米生物医学技术相关方面标准制定工作的现状,并探讨了生物医学领域纳米技术标准化工作的发展趋势.     

纳米医药学基本原理

纳米技术在医药学中的应用,已逐渐成为医药学的一个新的分枝。这一新的分枝称之为纳米医药学。纳米医药学中主要应用纳米粒子的三种基本功能:靶向作用、缓控释作用和跨生物屏障作用。目前对纳米技术应用研究较多的医药学领域包括用纳米材料制备人工生物结构、重大疾病的治疗及诊断。本文就有关方面进行最简要的讨论。     

纳米材料生物效应研究进展

随着纳米技术的快速发展,纳米材料在医学成像、疾病诊断、药物传输、癌症治疗、基因治疗等领域的应用和基础研究也在飞速发展.同时,纳米材料的这些有益应用使得人体通过吸入、经口、皮肤吸收和静脉注射等不同方式受到暴露.当纳米材料与生物体系发生相互作用时,有可能产生负面生物学效应,而这些潜在的毒理效应都是未知的.综述了纳米材料在生物医学领域巨大的应用前景,关注其对心血管系统、呼吸系统及转运到其他器官可能造成的负面效应,并探讨了纳米颗粒在引起心血管疾病及肺部炎症方面的可能机理与作用途径.最后对纳米材料的安全性评估和研究重点进行了总结.     

磁性纳米材料的生物医学应用进展

以四氧化三铁为代表的医用磁性纳米材料具有独特的磁学性能、表面易功能化、良好的生物学相容性等特点,在纳米医学相关领域展现出巨大的应用前景,特别是近年来它作为可介导外场的智能材料,在材料设计和生物医学应用方面均取得了突破性的进展.鉴于此,本文围绕磁性氧化铁纳米材料的生物医学应用,着重介绍近年来其在磁共振影像探针、磁热和磁力效应的生物医学应用、诊疗一体化以及纳米酶催化等领域的研究进展,并对磁性纳米材料在生物医学领域未来的发展方向进行了展望.     

硫化铜纳米粒子应用于肿瘤诊断和治疗的研究进展

癌症是当今威胁人类健康的主要疾病之一。近年来提出的近红外光介导的光热治疗,能够对肿瘤组织进行定点清除并且对正常组织具有较低的毒副作用,为肿瘤的治疗提供了新的方法。开发具有良好生物相容性的高效光热偶联剂是发展光热治疗的首要条件。随着纳米技术的飞速发展,一些金属纳米结构由于具有独特的光学特性作为光热偶联剂被广泛应用到肿瘤的光热治疗中。然而,成本高昂、制备过程繁琐以及光热稳定性较差等不足,限制了这些纳米材料的进一步应用。最新报道的新型光热偶联剂半导体硫化铜纳米粒子(copper sulfide nanoparticles,CuS NPs),由于其具有制备工艺简单、成本低廉、突出的光热稳定性和良好的生物相容性等优势,成为了当今纳米医学领域研究的热点。本文主要综述了CuS纳米粒子在肿瘤光热治疗和影像诊断方面的应用研究,并对CuS纳米粒子在生物医学领域应用中存在的问题和未来的研究方向进行了展望。     

当前生物医学发展趋势与特征研究

生物医学为许多医学问题的解决提供了有效依据,因此生物医学具有广阔的发展前景,要注重把握好其发展趋势及特征。本文结合实践经验分析了生物医学的发展趋势,包括纳米医学发展趋势、基因药物发展趋势及再生医学发展趋势;同时简单探讨了当前生物医学的发展特征,包括生物医学技术逐渐与计算机科技技术相互融合,研究领域由单因素问题逐渐过渡到多因素问题等。     

纳米佐剂在医学研究领域的应用进展

佐剂应用于临床已有90多年的历史,它的研究和应用取得了巨大的进展。自从20世纪80年代纳米技术首次应用于疫苗佐剂以来,纳米技术在医学上的应用受到越来越多的重视,新的纳米佐剂不断面世,在疫苗等研究领域发挥了重要作用。本文就目前正在研究使用的无机纳米佐剂和有机纳米佐剂作一简要综述。     

The intertwine of nanotechnology with the food industry

The past decade has proven the competence of nanotechnology in almost all known fields. The evolution of nanotechnology today in the area of the food industry has been largely and has had a lot of contribution in the food processing, food package, and food preservation. The increasing global human population has come with growing population to be fed, and food production is not adjusted to at par with the growing population. This mismatch has shown the real essence of food preservation so that food products can reach to people on a global scale. The introduction of nanotechnology in the food industry has made it easy to transport foods to different parts of the world by extending the shelf-life of most food products. Even with this beneficial aspect of nanotechnology, it has not been proven an entire full-proof measure, and the field is still open to changing technology. It suffices to note that nanotechnology has to a big extent succeed in curbing the extent of food wastage due to food spoilage by the microbial infestation. Nanotechnology has focused on fresh foods, ensuring a healthier food by employing nano-delivery systems in the process. The delivery systems are the ones, which carries the food supplements. However, these are certain sets of regulations that must be followed to tame or control the health related risks of nanotechnology in food industries. This paper outlines the role of nanotechnology at different levels of the food industry including, packaging of food, processing of food and the various preservation techniques all aiming to increase the shelf life of the food products.     

The Social Impacts of Nanotechnology: an Ethical and Political Analysis

This paper attempts some predictions about the social consequences of nanotechnology and the ethical issues they raise. I set out four features of nanotechnology that are likely to be important in determining its impact and argue that nanotechnology will have significant social impacts in—at least—the areas of health and medicine, the balance of power between citizens and governments, and the balance of power between citizens and corporations. More importantly, responding to the challenge of nanotechnology will require confronting “philosophical” questions about the sort of society we wish to create and the role that technology might play in creating it. This in turn will require developing institutions and processes that allow the public to wield real power in relation to technological trajectories. My ultimate contention is that the immediate task established by the likely social impacts of nanotechnology is not so much to develop an ethics of nanotechnology as to facilitate an ethical conversation about nanotechnology.

The SuperChip for microbial community structure,and function from all environments

We have the technology and capability to develop an all‐in‐one microarray that can provide complete information on a microbial community, including algae, protozoa, bacteria, archaea, fungi, viruses, antimicrobial resistance, biotoxins and functional activity. With lab‐on‐a‐chip, nanotechnology integrating a variety of the latest methods for a large number of sample types (water, sediment, waste water, food, blood, etc.) it is possible to make a desktop instrument that would have universal applications. There are two major thrusts to this grand challenge that will allow us to take advantage of the latest biotechnological breakthroughs in real time. The first is a bioengineering thrust that will take advantage of the large multidisciplinary laboratories in developing key technologies. Miniaturization will reduce reagent costs and increase sensitivity and reaction kinetics for rapid turnaround time. New and evolving technologies will allow us to port the designs for state‐of‐the‐art microarrays today to completely new nanotechnology inspired platforms as they mature. The second thrust is in bioinformatics to use our existing expertise to take advantage of the rapidly evolving landscape of bioinformatics data. This increasing capacity of the data set will allow us to resolve microbial species to greatly improved levels and identify functional genes beyond the hypothetical protein level. A cheap and portable assay would impact countless areas, including clean water technologies, emerging diseases, bioenergy, infectious disease diagnosis, climate change, food safety, environmental clean‐up and bioterrorism. In my opinion it is possible but it will require a very large group of multidiscplenary scientists from multiple institutions crossing many international boundaries and funding over a 5‐year period of more than $100 million. Given the impact that this SuperChip could have it is well worth the price!!!     

Identification of Risks in the Life Cycle of Nanotechnology‐Based Products

In order to realize the projected market potential of nanotechnology, the environmental, health, and safety (EHS) uncertainties posed by a nano‐product (i.e., a nanotechnology‐enabled product) need to be characterized through the identification of risks and opportunities in early stages of product development. We present a methodology to identify risks from nano‐products using a scenario analysis approach that allows for expert elicitation on a set of preidentified use and disposal scenarios and what we have labeled “risk triggers” to obtain scores on their likelihood of occurrence and severity. Use and disposal scenarios describe product life‐cycle stages that could result in risk attributed to the nano‐product, whereas risk triggers are particular to nanoparticle properties. These are potential risks, as the risk assessment community is currently debating the specific risks attributed to nanotechnology. Through such a framework, our goal is to identify which products pose greater risks, where these risks occur in the product life cycle, and the impacts of these environmental risks on society. The comparison of risk triggers across nano‐products allows relative risk ranking on axes of exposure‐ and hazard‐related risk triggers. For the specific case of air fresheners, areas of acute risks resulted from bioavailability of nanoparticles in air release and water entrainment exposure scenarios; catalytic activity of nanoparticles in inhalation and air release exposure scenarios; the harmful effects due to the antibacterial property on useful bacteria particularly in susceptible populations; and, finally, risks from the lack of nanoparticle coating stability in air release scenarios.     

Nano-regenerative medicine towards clinical outcome of stem cell and tissue engineering in humans

Nanotechnology is a fast growing area of research that aims to create nanomaterials or nanostructures development in stem cell and tissue-based therapies. Concepts and discoveries from the fields of bio nano research provide exciting opportunities of using stem cells for regeneration of tissues and organs. The application of nanotechnology to stem-cell biology would be able to address the challenges of disease therapeutics. This review covers the potential of nanotechnology approaches towards regenerative medicine. Furthermore, it focuses on current aspects of stem- and tissue-cell engineering. The magnetic nanoparticles-based applications in stem-cell research open new frontiers in cell and tissue engineering.     

Chiral nanotechnology

A review of chiral, nanoscale science and technology is presented, with the subject divided into two topics. The first discusses nanotechnology in the service of asymmetric synthesis, chiral separations, and analysis. The second topic concerns broader research in the nanotechnology realm, where molecular chirality plays a role in the properties of materials, including molecular devices, chiral supramolecules, chiral nanotubes, chiral fullerenes, and DNA nanotechnology.     

仿生纳米材料的设计与未来

自然合成了大量结构复杂、性能优越的有机、无机或有机无机杂化材料。这些材料与常规材料相比有着特殊的物理性质,从而造就了生物体各种奇异的功能。随着纳米技术的发展,研究发现许多生物体的特殊能力都与纳米技术息息相关。自然是一个先进的合成工厂,不断制造出具有各种奇异功能的生物体。而这些功能的实现,往往要依靠基本物质单元在微尺度上的有序或无序组装。对这些材料的探索和研究,为人们在微尺度上的仿生开辟了新的道路。本文针对仿生纳米材料的研究近况,展望此类材料的设计与未来发展趋势。     

用于肿瘤标志物检测的电化学免疫传感器

联合检测几种肿瘤标志物,在肿瘤早期诊断中具有重要的临床应用价值。随着纳米技术、流动注射分析技术、微流控技术以及丝网印刷术的迅猛发展,电化学免疫传感器可以在肿瘤标志物的检测中扮演越来越重要的角色。本文主要介绍了电化学免疫传感器的原理及其在肿瘤蛋白标志物检测中的应用情况,并介绍了纳米材料、流动注射分析、微流控等技术在肿瘤标志物免疫传感器中的运用,展望了电化学免疫传感器的前景。     

纳米技术与生物学实验的微型化

纳米技术是近年来发展迅速的新技术,有着几乎无限的潜力。一方面生物分子的尺度是纳米与亚纳米级的,纳米技术可以从生物科学学到许多生物分子作用的奥秘;另一方面,纳米技术为生物学的研究提供新材料、新方法,使生物学研究可以多快好省地进行。本文简单介绍几种利用纳米技术开展生物学研究的思路与方法。     

The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis

Nanotechnology, or systems/device manufacture at the molecular level, is a multidisciplinary scientific field undergoing explosive development. The genesis of nanotechnology can be traced to the promise of revolutionary advances across medicine, communications, genomics and robotics. Without doubt one of the greatest values of nanotechnology will be in the development of new and effective medical treatments (i.e., nanomedicine). This review focuses on the potential of nanomedicine as it specifically relates to (1) the development of nanoparticles for enabling and improving the targeted delivery of therapeutic agents; (2) developing novel and more effective diagnostic and screening techniques to extend the limits of molecular diagnostics providing point-of-care diagnosis and more personalized medicine.